| Evotec SE. (12/11/24). "Press Release: Evotec SE Announces First Projects for LAB eN² Drug Discovery Accelerator with Novo Nordisk". Pratteln. |
2024-12-11 |
| EQT AB. (12/11/24). "Press Release: EQT Life Sciences Leads Series B Extension in Noema Pharma, Raising Total Series B Financing to CHF 130 million". |
2024-12-11 |
| Antag Therapeutics. (12/4/24). "Press Release: Antag Therapeutics Announces €80 Million Series A Financing". Copenhagen. |
2024-12-04 |
| H. Lundbeck A/S. (11/18/24). "Press Release: Lundbeck Announces Expiration of Longboard Tender Offer and That All Tender Offer Conditions Are Fulfilled". |
2024-11-28 |
| Cradle Bio B.V.. (11/26/24). "Press Release: Cradle Raises $73m Series B Led by IVP to Accelerate Adoption of AI-powered Protein Engineering". Amsterdam & Zurich. |
2024-11-26 |
| Bico Group AB. (11/25/24). "Press Release: Cellink Announces Further Right-sizing and Launches Sharpened Commercial Agenda". |
2024-11-25 |
| Adcendo ApS. (11/25/24). "Press Release: Adcendo ApS Completes Oversubscribed $135 Million Series B Financing to Advance First-in-class ADC Pipeline". Copenhagen. |
2024-11-25 |
| Adragos Pharma GmbH. (11/25/24). "Press Release: Adragos Pharma Acquires Baccinex – a Leading Swiss Sterile Fill-Finish Expert". Munich & Courroux. |
2024-11-25 |
| Bico Group AB. (11/21/24). "Press Release: Bico Has Entered into an Agreement to Divest Nanoscribe". |
2024-11-21 |
| [iito] Business Intelligence / Kääb, Georg [ Itranskript ]. (11/13/24). "[LSG] Newsletter Special Issue: DACH Region Seed Financings 2020–2024. A List of 104 Deals with Comment & Analysis by Georg Kääb". Bremen & München. |
2024-11-13 |
| Alentis Therapeutics AG. (11/12/24). "Press Release: Alentis Therapeutics Raises $181.4 Million in an Oversubscribed Series D Financing to Advance the Clinical Development of Anti-Claudin-1 ADCs in Solid Tumors". Basel. |
2024-11-12 |
| Kivu Bioscience. (10/28/24). "Kivu Bioscience Raises $92 Million Series A Led by Novo Holdings to Advance Next-Generation Antibody-Drug Conjugates". San Francisco, CA. |
2024-10-28 |
| Ion Opticks Pty Ltd.. (10/25/24). "Press Release: Sciex and IonOpticks Announce Co-Marketing Agreement Between Aurora Series XS Range and the ZenoTOF Line". Melbourne. |
2024-10-25 |
| H. Lundbeck A/S. (10/14/24). "Press Release: Lundbeck to Acquire Longboard Pharmaceuticals in a Strategic Deal, Significantly Enhancing Its Neuroscience Pipeline". Valby & La Jolla, CA. |
2024-10-14 |
| Booster Therapeutics GmbH. (10/10/24). "Press Release: Booster Therapeutics Launches to Pioneer New Class of Proteasome Activator Medicines for the Treatment of a Range of Complex Diseases". Berlin. |
2024-10-10 |
| Calluna Pharma AS. (10/9/24). "Press Release: Calluna Pharma Appoints Mark Gaffney as Chief Executive Officer and Mark Altmeyer as Independent Chair of the Board". Oslo & Boston, MA. |
2024-10-09 |
| Ferring Pharmaceuticals S.A.. (10/3/24). "Press Release: Ferring Bolsters Global Gene Therapy Supply Chain with European Manufacturing Facility". Saint-Prex. |
2024-10-03 |
| Evotec SE. (9/26/24). "Press Release: Evotec and Novo Nordisk Enter into Technology Development Partnership to Support Next-generation Cell Therapies". Hamburg. |
2024-09-26 |
| NanoVation Therapeutics Inc.. (9/18/24). "Press Release: NanoVation Therapeutics Announces Multi-Target Partnership with Novo Nordisk to Develop Genetic Medicines Targeting Cardiometabolic and Rare Diseases". Vancouver, BC. |
2024-09-18 |
| Bioké (Cell Signaling Technology Europe B.V.). (9/16/24). "Press Release: Bioké and e-Blot Announce a Distribution Agreement in the European Region". Leiden. |
2024-09-16 |
| Ion Beam Applications S.A. (IBA). (9/11/24). "Press Release: IBA’s Joint Venture PanTera Secures EUR 93 Million in Oversubscribed Series A Round to Accelerate Global Actinium-225 Production". Louvain-la-Neuve. |
2024-09-11 |
| Ion Opticks Pty Ltd.. (9/10/24). "Press Release: IonOpticks Partners with Adelis to Accelerate Global Expansion and Innovation". Melbourne & Stockholm. |
2024-09-10 |
| Alentis Therapeutics AG. (9/3/24). "Press Release: Alentis Appoints Jonathan Freve CFO". Basel. |
2024-09-03 |
| BioArctic AB. (8/22/24). "Press Release: Leqembi (lecanemab) Authorized for Early Alzheimer’s Disease in Great Britain". Stockholm. |
2024-08-22 |
| Fujifilm Diosynth Biotechnologies UK Ltd.. (8/20/24). "Press Release: Fujifilm Diosynth Biotechnologies Celebrates Opening of Billingham, UK Microbial Manufacturing Facility". Billingham. |
2024-08-20 |
| Adcendo ApS. (8/20/24). "Press Release: Adcendo ApS and Multitude Therapeutics Inc. Announce Global Development and Commercialization Agreement on First-in-class ADC Drug Candidate Targeting Tissue Factor". Copenhagen & Shanghai. |
2024-08-20 |
| Bavarian Nordic A/S. (8/8/24). "Press Release: Bavarian Nordic Receives USD 156.8 Million from the U.S. Government for Additional Smallpox/Mpox Vaccine Production". Copenhagen. |
2024-08-08 |
| Biomatter Designs. (8/5/24). "Press Release: Biomatter Raises a €6.5 Million Seed Round to Unlock the Power of Generative AI for Enzyme Design". Vilnius. |
2024-08-05 |
| Valneva S.E.. (7/22/24). "Press Release: CEPI Expands Partnership with Valneva with a $41.3 Million Grant to Support Broader Access to the World’s First Chikungunya Vaccine". Oslo & Saint-Herblain. |
2024-07-22 |
| Draupnir Bio ApS. (7/1//24). "Press Release: Draupnir Bio Completes €12 Million Seed Round to Progress Development of Oral Small Molecule Degraders of Extracellular Proteins". Copenhagen. |
2024-07-17 |
| Asceneuron S.A.. (7/16/24). "Press Release: Asceneuron Secures $100 Million Series C Financing to Advance Groundbreaking Therapeutics in Neurodegenerative Diseases". Lausanne & San Francisco, CA. |
2024-07-16 |
| Bico Group AB. (7/10/24). "Press Release: Andréas Joersjö Appointed as General Counsel for Bico Group AB". |
2024-07-10 |
| HepaRegenix GmbH. (7/10/24). "Press Release: HepaRegeniX Raises €15 Million Series C Round to Advance Clinical Development of HRX-215 for Liver Regeneration". Tübingen. |
2024-07-10 |
| SciRhom GmbH. (7/9/24). "Press Release: SciRhom Secures EUR 63 Million Series A Financing Round to Accelerate iRhom2-targeting Therapies in Autoimmune Diseases". Munich. |
2024-07-09 |
| Myricx Pharma Ltd.. (7/8/24). "Press Release: Myricx Bio Announces £90m ($114m) Series A Financing to Advance its Novel NMTi-ADC Therapeutics into Clinical Development". London. |
2024-07-08 |
| Genovis AB. (7/4/24). "Press Release: Genovis Completes a Strategic Investment in Sequrna, a Developer of Next-generation RNase Inhibitors". Ghent. |
2024-07-04 |
| Forbion Capital Partners. (6/20/24). "Press Release: Forbion Announces First Close of Its New BioEconomy Fund I – Backing Biotech-enabled Companies Aiming to Impact the Future of Our Planet". Amsterdam. |
2024-06-20 |
| Hikma Pharmaceuticals plc. (6/17/24). "Press Release: Hikma Acquires Xellia’s Differentiated Portfolio and Enhances Injectables Pipeline, Manufacturing Capabilities and R&D". London. |
2024-06-17 |
| Coulter Partners. (6/12/24). "Press Release: Coulter Partners Announces Leadership Transition and Senior Leadership Team (SLT) Reorganization: Co-founder Bianca Coulter Becomes Executive Chair, Nicholas Green Appointed CEO". |
2024-06-12 |
| Moleculent AB. (6/11/24). "Press Release: Moleculent Launches with $26 Million Series A Financing to Advance the Spatial Mapping of Cell-Cell Communication". Stockholm. |
2024-06-11 |
| Macomics Ltd.. (6/10/24). "Press Release: Macomics Announces Appointment of Simon Dew as New Chief Business Officer". Edinburgh & Cambridge. |
2024-06-10 |
| Ardena Holding N.V.. (6/3/24). "Press Release: Ardena Appoints Jeremie Trochu as Chief Executive Officer". Ghent. |
2024-06-03 |
| BioNTech SE. (5/29/24). "Press Release: BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem". Mainz & Oslo. |
2024-05-29 |
| Adcendo ApS. (5/29/24). "Press Release: Adcendo ApS Announces Extension of Series A Financing to EUR 98M to Further Bolster its First-in-Class ADC Pipeline". Copenhagen. |
2024-05-29 |
| Asahi Kasei Corporation. (5/28/24). "Press Release: Asahi Kasei to Acquire Calliditas Therapeutics AB to Accelerate Growth as a Global Healthcare Company". |
2024-05-28 |
| TissUse GmbH. (5/28/24). "Press Release: Novel Liver Ring Trial Set to Revolutionize Drug Safety Assessment". Berlin. |
2024-05-28 |
| Origenis GmbH. (5/28/24). "Press Release: OncoBone Ventures and Origenis Announce Partnership to Develop Novel Therapies for Cancer Bone Metastasis". Tübingen & Boston, MA. |
2024-05-28 |
| Cellugy. (5/21/24). "Press Release: Danish Industrial Biotechnology Startup Cellugy Raises €4.9M to Replace Petrochemicals in Personal Care Products". Søborg. |
2024-05-21 |
| Single Use Support GmbH. (5/15/24). "Press Release: Novo Holdings Acquires Majority Stake in Single Use Support". Kufstein. |
2024-05-15 |
| ArgusEye AB. (5/13/24). "Press Release: ArgusEye Closes €2.8 Million Funding to Accelerate Bioprocessing". Stockholm. |
2024-05-13 |
| H. Lundbeck A/S. (5/13/24). "Press Release: Maria Alfaiate Appointed New Executive Vice President Commercial and Corporate Strategy at Lundbeck". |
2024-05-13 |
| Bluejay Therapeutics. (5/9/24). "Press Release: Bluejay Therapeutics Secures $182 Million in Series C Financing to Propel Clinical Pipeline". San Mateo, CA. |
2024-05-09 |
| Commit Biologics ApS. (5/9/24). "Press Release: Commit Biologics Launches with €16m Seed Financing to Pioneer Complement System Activation to Treat Cancer and Autoimmune Disease". Aarhus. |
2024-05-09 |
| Outcome Capital, LLC. (5/8/24). "Press Release: Outcome Capital Continues to Expand with the Addition of Industry Veteran Stanislav Glezer, MD MBA". Boston, MA. |
2024-05-08 |
| Insempra GmbH. (5/7/24). "Press Release: Insempra Completes $20 Million Financing to Advance the Development of Next-generation Bio-based Ingredients". Munich. |
2024-05-07 |
| Theolytics Ltd.. (4/17/24). "Press Release: Theolytics Successfully Closes Latest Financing Raising Total of £19M ($24.5M) and Welcomes Sound Bioventures as New Investor". Oxford. |
2024-04-17 |
| Nanoform Finland Oyj. (4/11/24). "Press Release: Nanoform Enters Exclusive Partnership with CBC to Bring Best-in-Class Nanomedicine Technology to Japan". Helsinki. |
2024-04-11 |
| Genmab A/S. (4/3/24). "Press Release: Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio". Copenhagen & Seattle, WA. |
2024-04-03 |
| Protembis GmbH. (3/26/24). "Press Release: Protembis Announces Completion of € 30 Million Series B Financing Round and the Addition of Keith D Dawkins MD to the Board of Directors". Aachen. |
2024-03-26 |
| CMS Hasche Sigle. (3/26/24). "Press Release: CMS Advises Sellers of Cardior Pharmaceuticals on Potential Acquisition by Novo Nordisk". Munich. |
2024-03-26 |
| Cardior Pharmaceuticals GmbH. (3/25/24). "Press Release: Novo Nordisk to Acquire Cardior Pharmaceuticals and Strengthen Pipeline in Cardiovascular Disease". Bagsværd & Hannover. |
2024-03-25 |
| Angelini Ventures S.p.A.. (3/21/24). "Press Release: Angelini Ventures Invests into Extended €75.8 Million ($82 Mmillion) Series C Financing Round for Nouscom". Rome. |
2024-03-21 |
| Bico Group AB. (3/15/24). "Press Release: Founders Leave after Eight Years". |
2024-03-15 |
| Amolyt Pharma SAS. (3/14/24). "Press Release: Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca. AstraZeneca Will Acquire Amolyt Pharma for up to $1.05 Billion in Total Consideration". Lyon & Cambridge, MA. |
2024-03-14 |
| Asgard Therapeutics AB. (3/14/24). "Press Release: Asgard Therapeutics Announces €30 Million Series A Financing to Advance Its First-in-Class in vivo Cell Reprogramming Platform for Immuno-oncology". Lund. |
2024-03-14 |
| Tubulis GmbH. (3/14/24). "Press Release: Tubulis Closes Upsized €128 Million Series B2 to Accelerate Clinical Development of Solid Tumor-Focused ADC Pipeline". Munich. |
2024-03-14 |
| Fida Biosystems ApS. (3/13/24). "Press Release: In-Solution Kinetics by Fida Biosystems – Redefining Drug Interaction Analysis for Therapeutic Discovery". Copenhagen. |
2024-03-13 |
| Gedea Biotech AB. (2/29/24). "Press Release: The Swedish Femtech Company Gedea Biotech Selected for Prestigious Grant Funding from the European Innovation Council, EIC". |
2024-02-29 |
| InflaRx N.V.. (2/22/24). "Press Release: InflaRx Appoints Jan Medina as Head of Investor Relations". Jena. |
2024-02-22 |
| Commit Biologics ApS. (2/14/24). "Press Release: Commit Biologics Receives Innobooster Grant from Innovation Fund Denmark Funding". |
2024-02-14 |
| FyoniBio GmbH. (2/7/24). "Press Release: FyoniBio Collaborates with BioLamina and Alder Therapeutics". Berlin. |
2024-02-07 |
| Nadmed Oy. (2/1/24). "Press Release: Effortless Measurement of All Four NADs and Glutathione for Laboratories". |
2024-02-01 |
| Aion Labs. (1/30/24). "Press Release: Aion Labs Launches New Startup Leveraging Machine Learning for Molecular Glue Discovery". Rehovot. |
2024-01-30 |
| BioIndustry Assocation (BIA). (1/30/24). "Press Release: BIA Reaches 600 Member Companies, Announces New Board and Leadership Restructure". Paris. |
2024-01-30 |
| Novonesis. (1/29/24). "Press Release: The Combination of Novozymes and Chr. Hansen Is Now Successfully Completed, Creating Novonesis – a Leading Global Biosolutions Partner". Copenhagen. |
2024-01-29 |
| BenevolentAI Ltd.. (1/24/24). "Press Release: BenevolentAI Appoints Dr. Joerg Moeller as Chief Executive Officer". London. |
2024-01-24 |
| IMU Biosciences (Melio Health UK Ltd.). (1/24/24). "Press Release: IMU Biosciences Secures £11.5 Million in Series A Funding to Revolutionise Immune Powered Precision Medicine". London. |
2024-01-24 |
| Eckert & Ziegler AG. (1/8/24). "Press Release: Eckert & Ziegler and ArtBio Announce Manufacturing and Supply Partnership for Lead-212 Conjugates". Berlin & Cambridge, MA. |
2024-01-08 |
| Vico Therapeutics B.V.. (1/5/24). "Press Release: Vico Therapeutics Announces $60 million (€54 million) Series B Financing to Advance VO659 Clinical-Stage Program for Rare Neurological Diseases and Expand Pipeline". Leiden. |
2024-01-05 |
| Novo Nordisk A/S. (1/4/24). "Press Release: Novo Nordisk Enters into Research Collaborations with Omega Therapeutics and Cellarity on Novel Treatment Approaches for Cardiometabolic Diseases". Bagsværd, Cambridge, MA & Somerville, MA. |
2024-01-04 |
| Merck KGaA. (1/4/24). "Press Release: Merck Expands Colorectal Cancer Portfolio Through Licensing Agreement with Inspirna [Not intended for UK-, US- or Canada-based media]". Darmstadt. |
2024-01-04 |
| Boehringer Ingelheim. (1/3/24). "Press Release: Boehringer Ingelheim Partners with Ribo to Develop New Treatments for People with Liver Diseases". Ingelheim, Mölndal & Kunshan. |
2024-01-03 |
| UPM Biomedicals. (12/21/23). "Press Release: UPM Biomedicals Enters into Distribution Agreement with Brinter for GrowInk Bioinks". |
2023-12-21 |
| Simris Group AB. (12/20/23). "Press Release: Simris Biologics Signs Material Transfer Agreement with Pre-clinical Biotech Company to Develop Linker-Payloads". |
2023-12-20 |
| LimmaTech Biologics AG. (12/19/23). "Press Release: LimmaTech Biologics Expands Vaccine Pipeline by Licensing AbVacc’s Innovative Vaccine Candidate Against Staphylococcus aureus". Schlieren & Rockville, MD. |
2023-12-19 |
| Shinobi Therapeutics Inc.. (12/12/23). "Press Release: Shinobi Therapeutics Launches with Completion of $51M Series A to Advance Hypoimmune iPS-T Cell Therapy Platform". San Francisco, CA & Kyoto. |
2023-12-12 |
| Freya Biosciences. (12/12/23). "Press Release: Freya Biosciences Announces $38 Million Funding in One of the Largest Series A Raises to Advance Women’s Reproductive Immunotherapies". Copenhagen. |
2023-12-12 |
| IBM Corporation. (12/5/23). "Press Release: AI Alliance Launches as an International Community of Leading Technology Developers, Researchers, and Adopters Collaborating Together to Advance Open, Safe, Responsible AI". |
2023-12-05 |
| AAX Biotech AB. (11/28/23). "Press Release: AAX Biotech Forms Strategic Collaboration with Oblique Therapeutics for Therapeutic Antibody Development". |
2023-11-28 |
| Cradle Bio B.V.. (11/28/23). "Press Release (Blog Post): Cradle Raises $24M Series A and Signs Partnerships with Industry Leaders". Delft & Zurich. |
2023-11-28 |
| Recipharm AB. (11/21/23). "Press Release: Marc Funk to Transition to Recipharm's Board of Directors; Greg Behar Appointed New CEO; Inhaled Business to Standalone in 2024". |
2023-11-21 |
| InDex Pharmaceuticals Holding AB. (11/21/23). "Press Release: InDex Pharmaceuticals Discontinues Cobitolimod Phase III Program". |
2023-11-21 |
| Owkin. (11/21/23). "Press Release: Owkin Expands Reach of AI Diagnostic for Colorectal Cancer through Integration with Sectra". |
2023-11-21 |
| Da Vinci Labs. (11/20/23). "Press Release: The European ‘SynBee Pitch Competition’ Will Reward Innovative Synthetic Biology Projects at SynBee Day 2024. Da Vinci Labs Is the New Coordinator of the SynBee Project". Reugny. |
2023-11-20 |
| NMD Pharma A/S. (11/15/23). "Press Release: NMD Pharma Raises €75 Million (~$80 million) in a Series B Financing". Aarhus. |
2023-11-15 |
| Bico Group AB. (11/13/23). "Press Release: Maria Forss Assumes Office as BICO’s CEO and President on November 20, 2023". |
2023-11-13 |
| Bico Group AB. (11/13/23). "Press Release: BICO Has Divested Ginolis through a Management Buy-out to Ginolis’ Current CEO Kauko Väinämö. The Purchase Price amounted to €1". |
2023-11-13 |
| VectorY Therapeutics B.V.. (11/13/23). "Press Release: VectorY Raises €129 Million ($138 Million) Series A Financing to Advance Vectorized Antibody Programs in Neurodegenerative Diseases". Amsterdam. |
2023-11-13 |
| AstraZeneca plc. (11/9/23). "Press Release: AstraZeneca Licenses Novel Agent for the Treatment of Cardiometabolic Conditions and Obesity [This press release is intended for investors and business / science media]". |
2023-11-09 |
| Kynexis B.V.. (11/7/23). "Press Release: Kynexis Launched to Advance Precision Therapeutics for Brain Diseases". Naarden. |
2023-11-07 |
![[LSS] Life-Sciences-Scandinavia.com - The Scandinavian Life Sciences Web Portal](/images/basics/lss-life-sciences-scandinavia-portal-logo.svg){kind=logo}
Date
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20230710-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
